NCT02608281View on ClinicalTrials.gov

Evaluation of Diagnostic Accuracy of Contrast Enhanced Dual Energy Mammography Imaging in Comparison to CE-MRI

NACompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

August 1, 2017

Study Completion Date

August 1, 2017

Conditions
Breast Cancer Diagnosis
Interventions
DEVICE

CONTRAST ENHANCED DUAL ENERGY (CEDEM)

The CEDEM application requires the intravenous injection of iodide contrast agents. For each projection view (CC, MLO) a low and a high energy x-ray image will be acquired after Iodine based contrast medium administration. Patient will undergo CE MRI procedure.

Trial Locations (1)

1090

Allgemeines Krankenhaus Wien, Vienna

All Listed Sponsors
collaborator

Medical University of Vienna

OTHER

lead

Siemens Healthcare QT

INDUSTRY

NCT02608281 - Evaluation of Diagnostic Accuracy of Contrast Enhanced Dual Energy Mammography Imaging in Comparison to CE-MRI | Biotech Hunter | Biotech Hunter